0001209191-20-053839.txt : 20201005
0001209191-20-053839.hdr.sgml : 20201005
20201005180106
ACCESSION NUMBER: 0001209191-20-053839
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201001
FILED AS OF DATE: 20201005
DATE AS OF CHANGE: 20201005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giles Lisa M.
CENTRAL INDEX KEY: 0001568850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 201224820
MAIL ADDRESS:
STREET 1: DURATA THERAPEUTICS, INC.
STREET 2: 200 SOUTH WACKER DRIVE SUITE 2550
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-01
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001568850
Giles Lisa M.
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTREAL
A8
H4M 2X6
QUEBEC, CANADA
1
0
0
0
Stock Option (right to buy)
7.10
2020-10-01
4
A
0
30000
0.00
A
2030-10-01
Common Shares
30000
30000
D
This option will vest in equal monthly installments, beginning on November 1, 2020, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date.
/s/ Jason Minio, Attorney-in-Fact
2020-10-05